With over thirty-years of experience in biopharmaceutical regulatory management and consulting, Terri joined GeoVax in 2023. Having held prior leadership roles with Genpact, Teva Pharmaceuticals, Pfizer, Centocor and MedImmune, Terri brings a broad view across the regulatory landscape having experience in regulatory strategy development, regulatory oversight of clinical trials, and the direct interaction with US and International Regulatory Authorities including submissions, inspections and reporting. She received her MS in Biotechnology from Johns Hopkins University and BS in Biology from William Paterson University.